| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70756-025-30 | 70756-025 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 2.5 mg/1 | 30 TABLET in 1 BOTTLE (70756-025-30) |
| 70756-293-30 | 70756-293 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 20 mg/1 | 30 TABLET in 1 BOTTLE (70756-293-30) |
| 70756-293-90 | 70756-293 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 20 mg/1 | 90 TABLET in 1 BOTTLE (70756-293-90) |
| 70756-291-30 | 70756-291 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 5 mg/1 | 30 TABLET in 1 BOTTLE (70756-291-30) |
| 70756-291-90 | 70756-291 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 5 mg/1 | 90 TABLET in 1 BOTTLE (70756-291-90) |
| 70756-292-30 | 70756-292 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 10 mg/1 | 30 TABLET in 1 BOTTLE (70756-292-30) |
| 70756-292-90 | 70756-292 | HUMAN PRESCRIPTION DRUG | Nebivolol | Nebivolol | TABLET | ORAL | 20221114 | N/A | ANDA | ANDA216172 | Lifestar Pharma LLC | NEBIVOLOL HYDROCHLORIDE | 10 mg/1 | 90 TABLET in 1 BOTTLE (70756-292-90) |